Skip to content

Clinical Trial Comparing Tissue Adhesive Vs. Absorbable Suture Vs. Non-Absorbable Suture

A Randomized Clinical Trial Comparing Tissue Adhesive (2-Octylcyanoacrylate) Vs. Absorbable Suture Vs. Non-Absorbable Suture for the Closure of Low Tension Facial and Neck Wounds in Children and Adolescents

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00292513
Enrollment
Unknown
Registered
2006-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2006-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cyst of Face, Neck or Shoulder, Pilomatrixoma of Face, Neck or Shoulder

Brief summary

Standard suture is superior to both tissue adhesive (2-octyl cyanoacrylate) and absorbable sutures with respect to cosmetic outcome of, complication rate of and parental satisfaction with the closure of low tension facial, neck and shoulder, wounds in children and adolescents

Interventions

DEVICEstandard suture (5-0 prolene), topical skin adhesive (dermabond), absorbable suture (5-0 Chromic gut)

Sponsors

Rady Children's Hospital, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Years to 18 Years

Inclusion criteria

* Age less than or equal to 18 * Pre-operative diagnosis of cyst or pilomatrixoma of neck, face or shoulder * outpatient scheduled for outpatient or day surgery at Children's Hospital San Diego

Exclusion criteria

* known hypersensitivity to cyanoacrylate or formaldehyde * lesions with any evidence of active infection or gangrene * lesions on or across mucocutaneous surfaces * lesions in which skin may be regularly exposed to body fluids * lesions located in areas of dense natural hair (ie scalp) * patients with peripheral vascular disease, insulin dependent diabetes mellitis or blood clotting disorders * patients with known immunodeficiencies * inability to return for follow-up

Countries

United States

Contacts

Primary ContactBari B Cunningham, MD
bcunningham@chsd.org858-576-1700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026